Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
type: MedicalStudy
description: A Phase 1, Multi-center, Open-label Study to Assess the Pharmacokinetics and Safety of BMS-986278 in Healthy Participants and Those With Mild, Moderate and Severe Hepatic Impairment
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2024-06-10
end date: 2024-12-30
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06425198
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Bristol-Myers Squibb
study subject: Hepatic Impairment
study subject: Healthy Participants
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Hepatic Impairment
keywords: Healthy Participants

AI Analytics
type: Organization